Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP1.3656 for Fatigue Following Ischemic Stroke
NCT05240560Phase 2Terminated
- Sponsor
- Bioprojet
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in fatigue comparing BP1.3656 with Placebo (2 arms). Primary endpoint: Multidimensional Fatigue Inventory global score at Week 8. Started Jan 2023; status: terminated.
02
Drugs
BP1.3656
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT05240560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05240560.